Cabometyx (cabozantinib)

pCPA File Number: 21238

Negotiation Status:

Concluded with an LOI

Indication(s):

For the treatment of Hepatocellular Carcinoma (HCC) in adults after prior therapy

Sponsor/Manufacturer:

Ipsen Biopharmaceuticals

CADTH Project Number:

pCODR 10186

pCPA Engagement Letter Issued:

2020-11-24

Negotiation Process Concluded:

2021-08-24